These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2956452)

  • 1. Renal and circulatory mechanisms in congestive heart failure.
    Dzau VJ
    Kidney Int; 1987 Jun; 31(6):1402-15. PubMed ID: 2956452
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in renal hemodynamics and renal function in patients with cardiac insufficiency treated with vasodilators].
    Leshchinskiĭ LA; Pimenov LT; Trusov VV
    Ter Arkh; 1981; 53(8):80-4. PubMed ID: 7292349
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal responses to atrial natriuretic factor in patients with congestive heart failure.
    Cody RJ; Atlas SA; Laragh JH
    Eur Heart J; 1988 Jun; 9 Suppl H():29-33. PubMed ID: 2971540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute vasodilator therapy increases renal clearance of digoxin in patients with congestive heart failure.
    Cogan JJ; Humphreys MH; Carlson CJ; Benowitz NL; Rapaport E
    Circulation; 1981 Nov; 64(5):973-6. PubMed ID: 7285311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandins, renin and atrial natriuretic peptide in the control of the circulation and renal function in heart failure in the dog.
    Riegger GA; Elsner D; Hildenbrand J; Koch K; Kromer EP
    Prog Clin Biol Res; 1989; 301():455-8. PubMed ID: 2529553
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathophysiology of edema in congestive heart failure.
    Navas JP; Martinez-Maldonado M
    Heart Dis Stroke; 1993; 2(4):325-9. PubMed ID: 8156185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal and congestive mechanisms in congestive heart failure].
    Uzelac S; Lazić M
    Vojnosanit Pregl; 1989; 46(1):47-51. PubMed ID: 2524932
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failure.
    Packer M
    Circulation; 1988 Jun; 77(6 Pt 2):I64-73. PubMed ID: 2967129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cardiac preload by atrial natriuretic peptide in congestive cardiac failure.
    Johnston CI; Hodsman GP; Harrison RW; Mendelsohn FA; Tsunoda K
    Am J Med; 1988 Mar; 84(3A):105-11. PubMed ID: 2851266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure.
    Cavero PG; De Marco T; Kwasman M; Lau D; Liu M; Chatterjee K
    J Am Coll Cardiol; 1992 Dec; 20(7):1542-8. PubMed ID: 1452928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrarenal effects of ecadotril during acute volume expansion in dogs with congestive heart failure.
    Solter P; Sisson D; Thomas W; Goetze L
    J Pharmacol Exp Ther; 2000 Jun; 293(3):989-95. PubMed ID: 10869402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of prostaglandins in regulation of kidney function in heart failure].
    Riegger AJ
    Herz; 1991 Apr; 16(2):116-23. PubMed ID: 2066053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kidney in congestive heart failure: 'are natriuresis, sodium, and diuretics really the good, the bad and the ugly?'.
    Verbrugge FH; Dupont M; Steels P; Grieten L; Swennen Q; Tang WH; Mullens W
    Eur J Heart Fail; 2014 Feb; 16(2):133-42. PubMed ID: 24464967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurohormonal activation, the renal dopaminergic system and sodium handling in patients with severe heart failure under vasodilator therapy.
    Ferreira A; Bettencourt P; Dias P; Pestana M; Serrão P; Soares-da-Silva P; Cerqueira-Gomes M
    Clin Sci (Lond); 2001 May; 100(5):557-66. PubMed ID: 11294697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-related hemodynamic and renal effects of dopamine in congestive heart failure.
    Beregovich J; Bianchi C; Rubler S; Lomnitz E; Cagin N; Levitt B
    Am Heart J; 1974 May; 87(5):550-7. PubMed ID: 4818699
    [No Abstract]   [Full Text] [Related]  

  • 16. The kidney in congestive heart failure.
    Ritz E; Fliser D
    Eur Heart J; 1991 Aug; 12 Suppl C():14-20. PubMed ID: 1915436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure.
    Martin FL; Stevens TL; Cataliotti A; Schirger JA; Borgeson DD; Redfield MM; Luchner A; Burnett JC
    Kidney Int; 2005 May; 67(5):1723-30. PubMed ID: 15840018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial natriuretic peptide in heart failure.
    Brandt RR; Wright RS; Redfield MM; Burnett JC
    J Am Coll Cardiol; 1993 Oct; 22(4 Suppl A):86A-92A. PubMed ID: 8376700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal hyporesponsiveness to atrial natriuretic peptide in congestive heart failure results from reduced atrial natriuretic peptide receptor concentrations.
    Bryan PM; Xu X; Dickey DM; Chen Y; Potter LR
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1636-44. PubMed ID: 17264312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac and renal effects of growth hormone in volume overload-induced heart failure: role of NO.
    Pagel I; Langenickel T; Höhnel K; Philipp S; Nüssler AK; Blum WF; Aubert ML; Dietz R; Willenbrock R
    Hypertension; 2002 Jan; 39(1):57-62. PubMed ID: 11799079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.